Sawan Kumar Jha

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Intellectual Disability

Endothelial Cells

Top Venues

Scientific reports

Science translational medicine

University of Helsinki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki Jan 01 2015

Finland

Ph.D fellow :: Medicine

Publications

Ravi Kant, Lauri Kareinen, Teemu Smura, Tobias L Freitag, Sawan Kumar Jha, Kari Alitalo, Seppo K Meri, Tarja A Sironen, Kalle Saksela, Tomas M Strandin, Anja Kipar, Olli Vapalahti
Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant. Viruses 13 (11) (2021)
Veli-Matti Leppänen, Pascal Brouillard, Emilia A Korhonen, Tuomas Sipilä, Sawan Kumar Jha, Nicole Revencu, Veerle Labarque, Elodie Fastré, Matthieu Schlögel, Marie Ravoet, Amihood Singer, Claudia Luzzatto, Donatella Angelone, Giovanni Crichiutti, Angela D'Elia, Jaakko Kuurne, Harri Elamaa, Gou Young Koh, Pipsa Saharinen, Miikka Vikkula, Kari Alitalo
Characterization of ANGPT2 mutations associated with primary lymphedema. Science translational medicine 12 (560) (2021)
Sawan Kumar Jha, Khushbu Rauniyar, Ewa Chronowska, Kenny Mattonet, Eunice Wairimu Maina, Hannu Koistinen, Ulf-Håkan Stenman, Kari Alitalo, Michael Jeltsch
KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D. eLife 8 (2019)
Sawan Kumar Jha, Khushbu Rauniyar, Terhi Karpanen, Veli-Matti Leppänen, Pascal Brouillard, Miikka Vikkula, Kari Alitalo, Michael Jeltsch
Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1. Scientific reports 7 (1) (2017)